| SYS | | 0061167 |
|---|
| LBL | | 00000naa^^22^^^^^^^^450 |
|---|
| 005 | | 20150319144015.1 |
|---|
| 100 | | $a 20110408a2011 m y0sloy0103 ba |
|---|
| 101 | 0- | $a eng $d eng |
|---|
| 102 | | $a SK |
|---|
| 200 | 1- | $a Prohibitin as a novel target protein of luteinizing hormone in ovarian epithelial carcinogenesis $f L. Jia ... [et al.] |
|---|
| 215 | | $c ilustr., grafy, obr., tab. |
|---|
| 320 | | $a Bibliogr. odkazy |
|---|
| 320 | | $a Res. angl. |
|---|
| 463 | -1 | $1 001 sllk_un_cat*0060253 $1 011 $a 0028-2685 $1 200 1 $a Neoplasma $e journal of experimental and clinical oncology $f Cancer Research Institute of the Slovak Academy of Sciences $v Vol. 58, no. 2 (2011), s.104-109 $1 210 $a Bratislava $c AEPress $d 2011 $1 215 $a 97-180 |
|---|
| 541 | 1- | $a Prohibitín ako nový cieľový proteín luteinizačného hormónu v epiteliálnej karcinogenéze vaječníkov $z slo |
|---|
| 606 | 1- | $3 sllk_un_auth*d010051 $a nádory vaječníkov $x etiológia $x patológia $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d006062 $a gonadotropíny $x krv $x použitie terapeutické $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d007986 $a hormón luteinizačný $2 mesh |
|---|
| 606 | 1- | $3 sllk_un_auth*d011506 $a proteíny $x analýza $2 mesh |
|---|
| 606 | 2- | $3 sllk_un_auth*d007150 $a imunohistochémia $2 mesh |
|---|
| 610 | 2- | $a prohibitín |
|---|
| 610 | 2- | $a expresia prohibitínu |
|---|
| 610 | 2- | $a analýza proteómová porovnávacia |
|---|
| 610 | 2- | $a cystadenóm vaječníkov serózny benígny |
|---|
| 610 | 2- | $a karcinogenéza |
|---|
| 701 | -1 | $3 sllk_un_auth*0020136 $a Jia $b L. $p Department of obstetrics and gynecology, Qilu Hospital, Shandong University, Jinan, China $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0020137 $a Yi $b X. F. $p Hospital of obstetrics and gynecology, Fudan University, Shangai, China $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0020138 $a Zhang $b Z. B. $p Department of obstetrics and gynecology Shanghai first municipal hospital. Jiaotong University, Shanghai, China $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0020139 $a Zhuang $b Z. P. $p Molecular pathogenesis unit, Surgical neurology branch, National institute of neurological disorders and stroke, National institutes of health, Bethesda, USA $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0020140 $a Li $b J. $p Molecular pathogenesis unit, Surgical neurology branch, National institute of neurological disorders and stroke, National institutes of health, Bethesda, USA $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0020141 $a Chambers $b S. K. $p Arizona cancer center, University of Arizona, Tucson, USA $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0007934 $a Kong $b B. $p Department of Obstetrics and Gynecology, Qilu Hospital, Shandong University, Shandong, China $4 070 |
|---|
| 701 | -1 | $3 sllk_un_auth*0020142 $a Zheng $b W. $p Department of obstetrics and gynecology, Qilu Hospital, Shandong University, Jinan, China $4 070 |
|---|
| 801 | -0 | $a SK $b BA006 $c 20110408 $g AACR2 |
|---|
